Scarica l'app Stockscreener
1.1842
4.44%
-0.0558
Allogene Therapeutics Inc Azioni (ALLO) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
-
|
- | - | - | 0.022 |
Operating Expenses
|
7.77%
65.19
|
60.49 | 71.77 | 71.43 | 69.53 |
| Operating Income/Loss |
7.77%
-65.19
|
-60.49 | -71.77 | -71.43 | -69.50 |
| Nonoperating Income/Loss |
449.09%
5.458
|
0.994 | 5.481 | 5.073 | 4.504 |
| Income/Loss From Equity Method Investments |
-
|
- | -1.134 | 0.375 | -0.929 |
| Income/Loss From Continuing Operations Before Tax |
0.40%
-59.73
|
-59.50 | -66.29 | -66.36 | -65.00 |
| Income/Loss From Continuing Operations After Tax |
0.34%
-59.73
|
-59.94 | -66.29 | -66.36 | -65.00 |
|
Net Income/Loss
|
0.34%
-59.73
|
-59.94 | -66.29 | -66.36 | -65.00 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
3,970%
215.36
|
5.2919 | 209.19 | 190.03 | 169.13 |
| Diluted Average Shares |
3,970%
215.36
|
5.2919 | 209.19 | 190.03 | 169.13 |
| Basic Earnings Per Share |
0.00%
-0.28
|
-0.28 | -0.32 | -0.35 | -0.38 |
| Diluted Earnings Per Share |
0.00%
-0.28
|
-0.28 | -0.32 | -0.35 | -0.38 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.66%
0.84%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):